Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.
about
Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of T-cell activatio ...... te proteinuric kidney disease.
@en
type
label
Inhibition of T-cell activatio ...... te proteinuric kidney disease.
@en
prefLabel
Inhibition of T-cell activatio ...... te proteinuric kidney disease.
@en
P2093
P2860
P1476
Inhibition of T-cell activatio ...... ate proteinuric kidney disease
@en
P2093
Alison Bigley
Angela M Valverde
Barbara Valastro
Beatriz Santamaria
Carol Moreno Quinn
Cristina Rondinone
David Baker
Johan Mölne
Lutz Jermutus
Magnus Söderberg
P2860
P304
P356
10.1152/AJPRENAL.00179.2016
P50
P577
2016-07-20T00:00:00Z